Beta-Selinene

Beta-Selinene

SCHEMBL309336

C=C(C)[C@@H]1CC[C@@]2(C)CCCC(=C)[C@@H]2C1

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.64
TRPA1 O75762 1/20 0.58
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
STAT3 P40763 1/20 0.41
NLRP3 Q96P20 1/20 0.41
CYP3A4 P08684 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
KMT2A Q03164 8/20 0.36
MEN1 O00255 6/20 0.36
ALOX5 P09917 1/20 0.36
DRD2 P14416 1/20 0.36
SOAT1 P35610 1/20 0.36
POLB P06746 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MITF O75030 1/20 0.34
ATM Q13315 1/20 0.34
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Beta-Selinene SCHEMBL17629434 1.00 PTPN1 (0.64) PTPN1TRPA1CYP2D6CYP2C9CYP2C19
Beta-Selinene SCHEMBL29975200 1.00 PTPN1 (0.64) PTPN1TRPA1CYP2D6CYP2C9CYP2C19
Beta-Selinene SCHEMBL28349419 1.00 PTPN1 (0.64) PTPN1TRPA1CYP2D6CYP2C9CYP2C19
Beta-Selinene SCHEMBL30105712 1.00 PTPN1 (0.64) PTPN1TRPA1CYP2D6CYP2C9CYP2C19
SCHEMBL14189192 0.84 PTPN1 (0.67) PTPN1TRPA1CYP2D6CYP2C9CYP2C19
SCHEMBL30048421 0.84 PTPN1 (0.67) PTPN1TRPA1CYP2D6CYP2C9CYP2C19
SCHEMBL29409800 0.84 PTPN1 (0.67) PTPN1TRPA1CYP2D6CYP2C9CYP2C19
Costic Acid SCHEMBL30049186 0.82 PTPN1 (0.56) PTPN1TRPA1CYP2D6CYP2C9CYP2C19
Isocyperol SCHEMBL29477342 0.78 PTPN1 (0.44) PTPN1TRPA1NLRP3POLBSMN1; SMN2
Isocyperol SCHEMBL16663911 0.78 PTPN1 (0.44) PTPN1TRPA1NLRP3POLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1517 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4717088-A1 METHOD FOR IMPROVING THE CULTIVATION OF PLANTS UNDER ABIOTIC STRESS CONDITIONS Timac Agro España, S.A. (ES) 2026-04-01 EP claimed
EP-4593977-A1 PRODUCTS AND METHODS RELATED TO THE DISTILLATION OF MOLECULES FROM AEROSOLS Natural Extraction Systems, LLC (US) 2025-08-06 EP claimed
US-20250073252-A1 NON-PSYCHOACTIVE MULTI-CANNABINOID AND TERPENE-BASED THERAPEUTIC COMPOSITIONS AND METHODS OF THEIR ADMINISTRATION PEBBLE GLOBAL HOLDINGS (US) 2025-03-06 US claimed
WO-2025027218-A1 METHOD FOR IMPROVING THE CULTIVATION OF PLANTS UNDER ABIOTIC STRESS CONDITIONS TIMAC AGRO ESPAÑA, S.A., (ES) 2025-02-06 WO claimed
EP-4096618-B1 A MIXTURE COMPRISING 1,2-ALKANEDIOLS SYMRISE AG (DE) 2025-01-29 EP claimed
US-20240417153-A1 ECO-FRIENDLY CUP HOLDER AND METHOD OF MANUFACTURING SAME SM TEXTILE CO., LTD. (KR) 2024-12-19 US claimed
EP-4438065-A2 A MIXTURE COMPRISING 1,2-ALKANEDIOLS Symrise AG (DE) 2024-10-02 EP claimed
US-20240189737-A1 COMPOSITIONS FOR LOW-TEMPERATURE DISTILLATION OF HIGH-BOILING-POINT MOLECULES Natural Extraction Systems, LLC 2024-06-13 US claimed
US-20240181369-A1 PRODUCTS AND METHODS RELATED TO THE DISTILLATION OF MOLECULES FROM AEROSOLS Natural Extraction Systems, LLC 2024-06-06 US claimed
EP-4373507-A1 METHODS AND COMPOSITIONS FOR MICROENCAPSULATED COMPOUNDS Ojai Energetics PBC (US) 2024-05-29 EP claimed
US-20040234487-A1 Polyurethane and polyurethane-based mixed graft polymers and their use for producing coating materials, adhesives and sealing compounds BASF COATINGS AKTIENGESELLSCHAFT (DE) 2004-11-25 US claimed
WO-2004066912-A2 ANTI-INFLAMMATORY COMPOSITIONS AND USES THEREOF TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD. (IL) 2004-08-12 WO claimed
US-20040057908-A1 Oral compositions and use thereof NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2004-03-25 US claimed
EP-1399119-A2 ORAL COMPOSITIONS AND USE THEREOF University of Rochester (US) 2004-03-24 EP claimed
US-20030138471-A1 Biorational repellents obtained from terpenoids for use against arthropods IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. 2003-07-24 US claimed
US-6543181-B1 Mixture of volatile acid, alcohol and nitrogen compound IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. 2003-04-08 US claimed
WO-2002047615-A2 ORAL COMPOSITIONS AND USE THEREOF UNIVERSITY OF ROCHESTER (US) 2002-06-20 WO claimed
EP-0831696-B1 TERPENES FOR REDUCING THE EFFECT OF PHEROMONE ON LEPIDOPTERA BASF AG (DE) 2001-11-14 EP claimed
US-6110449-A ANTIPERSPIRANT, PERFUMES, CYCLODEXTRIN INCLUSION COMPLEX ANDCARRIERS THE PROCTER & GAMBLE COMPANY (US) 2000-08-29 US claimed
WO-1999011612-A2 SUBSTITUTED CYCLIC COMPOUNDS AND MIXTURES COMPRISING SAME ISIS PHARMACEUTICALS, INC. (US) 1999-03-11 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040234487-A1 Polyurethane and polyurethane-based mixed graft polymers and their use for producing coating materials, adhesives and sealing compounds PUF60, UROD, CAD PTPN1 4870/4885TRPA1 1964/4885CYP2D6 3864/4885
US-20040057908-A1 Oral compositions and use thereof UGGT1, DPM1, B4GALT1 PTPN1 4335/4885TRPA1 1155/4885CYP2D6 419/4885
US-20030138471-A1 Biorational repellents obtained from terpenoids for use against arthropods MME, FNTA, ACE PTPN1 2030/4885TRPA1 1382/4885CYP2D6 3522/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.